Who
Richard A. Young
Director
Company insider
Files Form 4 as: Director, CAMP4 Therapeutics; Director, Syros Pharmaceuticals; Director, Omega Therapeutics; Director, Enzon Pharmaceuticals.
In numbers
- Trades disclosed
- 64
- Buys
- 2
- Sells
- 26
- Bought
- $79K
- Sold
- $1.8M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 19 Apr 2010
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $27K16,378 at $1.65 | filing |
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $27K16,378 at $1.65 | filing |
| 10 Jun 2026filed 12 Jun 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 11 Sep 2025filed 11 Sep 2025 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $25K15,151 at $1.65 | filing |
| 25 Jun 2025filed 27 Jun 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 15 Oct 2024filed 15 Oct 2024 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —100,014 | filing |
| 15 Oct 2024filed 15 Oct 2024 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Code C | —8,917 | filing |
| 16 Sep 2024filed 18 Sep 2024 | Syros Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —2,667 at $0.00 | filing |
| 16 Sep 2024filed 18 Sep 2024 | Syros Pharmaceuticals | SEC FORM 4 Code M | —2,667 | filing |
| 28 Jun 2024filed 2 Jul 2024 | Syros Pharmaceuticals | SEC FORM 4 Sold | $178K34,837 at $5.12 | filing |
| 20 Jun 2024filed 21 Jun 2024 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | Syros Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | Syros Pharmaceuticals | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 16 Sep 2023filed 19 Sep 2023 | Syros Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —2,666 at $0.00 | filing |
| 16 Sep 2023filed 19 Sep 2023 | Syros Pharmaceuticals | SEC FORM 4 Code M | —2,666 | filing |
| 7 Jun 2023filed 9 Jun 2023 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —18,118 at $0.00 | filing |
| 2 Jun 2023filed 5 Jun 2023 | Omega Therapeutics | SEC FORM 4 Sold | $40K5,000 at $8.00 | filing |
| 1 Jun 2023filed 2 Jun 2023 | Syros Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 1 Jun 2023filed 2 Jun 2023 | Syros Pharmaceuticals | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.